Back
MercadoLibre 10K Form
Buy
64
MELI
MercadoLibre
Last Price:
$2,385.09
Seasonality Move:
12.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | MELI/MercadoLibre Quarterly |
2023-11-02 | 10Q | MELI/MercadoLibre Quarterly |
2023-08-03 | 10Q | MELI/MercadoLibre Quarterly |
2023-05-04 | 10Q | MELI/MercadoLibre Quarterly |
2022-11-04 | 10Q | MELI/MercadoLibre Quarterly |
2022-08-04 | 10Q | MELI/MercadoLibre Quarterly |
Receive MELI News And Ratings
See the #1 stock for the next 7 days that we like better than MELI
MELI Financial Statistics
Sales & Book Value
Annual Sales: | $20.8B |
---|---|
Cash Flow: | $759M |
Price / Cash Flow: | 18.83 |
Annual Sales: | $98.70 |
Price / Book: | 24.28 |
Profitability
EPS (TTM): | 40.66000 |
---|---|
Net Income (TTM): | $2.1B |
Gross Margin: | $9.6B |
Return on Equity: | 50.51% |
Return on Assets: | 8.99% |
MercadoLibre Earnings Forecast
Key MercadoLibre Financial Ratios
-
The Gross Profit Margin over the past 23 years for MELI is 46.09%.
-
The Selling, General & Administrative Expenses for MELI have been equal to 15.18% of Gross Profit Margin.
-
The Research & Development expenses have been 9.31% of Revenue.
-
The Interest Expense is 8.63% of Operating Income.
-
The Net Earning history of MELI is 9.20% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 16 years.
MercadoLibre Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Broadline Retail |
Sector: | Consumer Discretionary |
Current Symbol: | MELI |
CUSIP: | 58733R |
Website: | mercadolibre.com |
Debt
Debt-to-Equity Ratio: | 1.26 |
---|---|
Current Ratio: | 1.2 |
Quick Ratio: | 0.83 |
Price-to-Earnings
Trailing P/E Ratio: | 63.58 |
---|---|
Forward P/E Ratio: | 35.58 |
MELI Technical Analysis vs Fundamental Analysis
Buy
64
MercadoLibre (MELI)
is a Buy
Is MercadoLibre a Buy or a Sell?
-
MercadoLibre stock is rated a BuyThe current MercadoLibre [MELI] share price is $2,396.44. The Score for MELI is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.